117 related articles for article (PubMed ID: 19879362)
1. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury.
Liu Y; Figley S; Spratt SK; Lee G; Ando D; Surosky R; Fehlings MG
Neurobiol Dis; 2010 Feb; 37(2):384-93. PubMed ID: 19879362
[TBL] [Abstract][Full Text] [Related]
2. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH
Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407
[TBL] [Abstract][Full Text] [Related]
3. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
4. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A.
D'Onofrio PM; Thayapararajah M; Lysko MD; Magharious M; Spratt SK; Lee G; Ando D; Surosky R; Fehlings MG; Koeberle PD
J Neurotrauma; 2011 Sep; 28(9):1863-79. PubMed ID: 21902538
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.
Price SA; Dent C; Duran-Jimenez B; Liang Y; Zhang L; Rebar EJ; Case CC; Gregory PD; Martin TJ; Spratt SK; Tomlinson DR
Diabetes; 2006 Jun; 55(6):1847-54. PubMed ID: 16731852
[TBL] [Abstract][Full Text] [Related]
7. Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors.
Snowden AW; Zhang L; Urnov F; Dent C; Jouvenot Y; Zhong X; Rebar EJ; Jamieson AC; Zhang HS; Tan S; Case CC; Pabo CO; Wolffe AP; Gregory PD
Cancer Res; 2003 Dec; 63(24):8968-76. PubMed ID: 14695215
[TBL] [Abstract][Full Text] [Related]
8. An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice.
Yu J; Lei L; Liang Y; Hinh L; Hickey RP; Huang Y; Liu D; Yeh JL; Rebar E; Case C; Spratt K; Sessa WC; Giordano FJ
FASEB J; 2006 Mar; 20(3):479-81. PubMed ID: 16423874
[TBL] [Abstract][Full Text] [Related]
9. Induction of HIF1alpha but not HIF2alpha in motoneurons after ventral funiculus axotomy-implication in neuronal survival strategies.
Sköld MK; Marti HH; Lindholm T; Lindå H; Hammarberg H; Risling M; Cullheim S
Exp Neurol; 2004 Jul; 188(1):20-32. PubMed ID: 15191799
[TBL] [Abstract][Full Text] [Related]
10. Regulation of endogenous gene expression using small molecule-controlled engineered zinc-finger protein transcription factors.
Dent CL; Lau G; Drake EA; Yoon A; Case CC; Gregory PD
Gene Ther; 2007 Sep; 14(18):1362-9. PubMed ID: 17637799
[TBL] [Abstract][Full Text] [Related]
11. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury.
Figley SA; Liu Y; Karadimas SK; Satkunendrarajah K; Fettes P; Spratt SK; Lee G; Ando D; Surosky R; Giedlin M; Fehlings MG
PLoS One; 2014; 9(5):e96137. PubMed ID: 24846143
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury.
Kitamura K; Iwanami A; Nakamura M; Yamane J; Watanabe K; Suzuki Y; Miyazawa D; Shibata S; Funakoshi H; Miyatake S; Coffin RS; Nakamura T; Toyama Y; Okano H
J Neurosci Res; 2007 Aug; 85(11):2332-42. PubMed ID: 17549731
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of anti-apoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury.
Tamura M; Nakamura M; Ogawa Y; Toyama Y; Miura M; Okano H
Glia; 2005 Sep; 51(4):312-21. PubMed ID: 15846791
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
[TBL] [Abstract][Full Text] [Related]
15. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors.
Kao CH; Chen SH; Chio CC; Lin MT
Shock; 2008 Jan; 29(1):49-55. PubMed ID: 17666954
[TBL] [Abstract][Full Text] [Related]
19. Zinc-finger transcriptional factor Sall1 induces angiogenesis by activation of the gene for VEGF-A.
Yamamoto C; Fukuda N; Matsumoto T; Higuchi T; Ueno T; Matsumoto K
Hypertens Res; 2010 Feb; 33(2):143-8. PubMed ID: 19942929
[TBL] [Abstract][Full Text] [Related]
20. Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A.
Siddiq I; Park E; Liu E; Spratt SK; Surosky R; Lee G; Ando D; Giedlin M; Hare GM; Fehlings MG; Baker AJ
J Neurotrauma; 2012 Nov; 29(17):2647-59. PubMed ID: 23016562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
